CLINICAL_TRIALS
trial_result
· 2020-12-17
Clinical Trial Update: Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing [Phase 2]
Summary
Phase 2 trial evaluating an alternative dosing schedule of sunitinib in metastatic renal cell carcinoma, using cardiopulmonary exercise testing to assess tolera…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED | Results posted: 2020-12-17